Herpes simplex virus (HSV) conjunctivitis,
in newborns, 56
Herpetic gingivostomatitis (HGS), 63–64
Hgb Ss cell disease, 132–135, 135f
High-risk behaviors, 6
in preteens, 24
in school-aged child, 24
in teens, 27
High-risk population, 6
Hip dysplasia, 285–287
Hip subluxation, 286
Hirschsprung disease, 242–243
History, client, 33–37. See also specific
disorders
communication in, 33–34
family assessment in, 36–37, 37f
nursing history in, 34
nutritional assessment in, 35–36
psychosocial assessment in, 34
History, nursing, 34
Hodgkin lymphoma, 158–160
Host, susceptible, 303
Human herpes virus 6, 315–316
Human parvovirus B19, 311
Hydrocephalus, 223f, 224–225
Hyperglycemia, in diabetes mellitus, 188
Hyperkalemia, 261–262
Hyperopia, 54
Hypertelorism, 40
Hyperthyroidism, 190–191
Hypoglycemia, in diabetes mellitus, 188
Hypoglycemic agents, oral, 186t, 187–188, 187t
Hypoplastic anemia, 126–129
Hypospadia, 263
Hypothalamus, 178f, 200
Hypothermia, in newborn/infant, 17
Hypothyroidism, congenital, 181–182
I
Idiopathic thrombocytopenic purpura (ITP), 139
Ileocecal valve, 232
Ileum, 232
Illness, 303
Illness potential
in newborn/infant, 17
in school-aged child, 23–24
in teens, 27
Index^371
Immigrants, recent, 7
Immune system, 303
Immunity
artificially acquired active, 303
artificially acquired passive, 303
natural, 303
naturally acquired active, 303
naturally acquired passive, 303
Immunizations.SeeVaccinations; specific types
Impetigo, 335–336
Inactivated poliovirus vaccine (IPV), 314
Inactivated vaccinations, 304
Incubation period, 303
Induction therapy, for leukemia, 157
Infantile spasms, 202
Infection risk, in newborn/infant, 17
Infectious diseases, 302–321. See also specific
diseases
anaphylaxis, 319–320
bacteria in, 305
case study on, 321
chain of infection in, 302–303
diphtheria, 305–306
fifth disease, 311–312
Haemophilus influenzaetype B, 306–308
immune system and, 303
lymphocytes and, 303–304
mononucleosis, 320–321
mumps, 312–314
pertussis, 308–310
poliomyelitis, 314–315
roseola infantum, 315–316
rubella, 316–317
rubeola, 317–318
stages of infection in, 303
tetanus, 310–311
vaccinations against, 304–305 (See also
Vaccinations; specific types)
varicella zoster virus, 318–319
viruses in, 305
Infectious mononucleosis, 79–80, 320–321
Inferior vena cava, 92, 93f, 94f
Influenza virus, 74
Injury potential
in newborn/infant, 17
in school-aged child, 23–24
in teens, 27